Skip to main content
. 2014 Jun;5(3):53–61. doi: 10.1177/2042018814544153

Figure 1.

Figure 1.

Direct effects of sodium glucose transporter-2 (SGLT2) inhibition in the kidney.

PCG, intraglomerular capillary pressure; RAAS, renin–angiotensin aldosterone system; SGLT2i, sodium glucose transporter-2 inhibitor; TGF, tubuloglomerular feedback.